<DOC>
	<DOCNO>NCT02781649</DOCNO>
	<brief_summary>In study , individual without hepatitis C infection kidney transplant waitlist receive kidney decease donor hepatitis C infection treat hepatitis C time . Treatment include Grazoprevir ( GZR ) 100 mg/Elbasvir ( EBR ) 50 mg administer on-call operating room renal transplant procedure continue 12 week post-renal transplant .</brief_summary>
	<brief_title>Exploring Renal Transplants Using Hepatitis C Infected Donors HCV-negative Recipients</brief_title>
	<detailed_description>In study , individual without hepatitis C infection kidney transplant waitlist receive kidney decease donor hepatitis C infection treat hepatitis C time . Hepatitis C treatment include Grazoprevir ( GZR ) 100 mg/Elbasvir ( EBR ) 50 mg administer on-call operating room renal transplant procedure continue 12 week post-renal transplant . The donor hepatitis C genotype test . If donor genotype 1a without resistance genotype 1b treatment remain GZR/EBR 12 week . If donor genotype 1a resistance variant , Ribavirin add treatment give 16 week start date ribavirin add . If donor hepatitis C genotype 2 3 , Sofosbuvir add treatment 12 week date Sofosbuvir add .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Sofosbuvir</mesh_term>
	<criteria>Participants ≥ 50 year old On deceased donor kidney wait list Johns Hopkins Hospital Awaiting first kidney transplant No available live kidney donor On hemodialysis peritoneal dialysis stage 5 chronic kidney disease ( CKD ) define glomerular filtration rate &lt; 15 ml/min ≥ past 90 day HCVuninfected ( antibody RNA PCR ) without behavioral risk factor contract HCV hemodialysis . Calculated panel reactive antihuman leukocyte antigen ( HLA ) antibody ( cPRA ) 20 percent Female : practicing total abstinence sexual intercourse ( minimum 1 complete menstrual cycle ) sexually active female partner childbearing potential : define postmenopausal least 2 year prior screen define amenorrheic longer 2 year , age appropriate , confirm folliclestimulating hormone level indicate postmenopausal state , surgically sterile : defined bilateral tubal ligation , bilateral oophorectomy hysterectomy vasectomized partner ( ) ; childbearing potential sexually active male partner ( ) : currently use least one effective method birth control time screen agree practice two effective method birth control receive study drug ( outline participant information consent form start Study Day 1 30 day stop study drug , 6 month stop study drug receive RBV ( Note : Estrogencontaining hormonal contraceptive , include oral , injectable , implantable , patch ring variety , may use study drug treatment ) . Males surgically sterile sexually active female partner ( ) childbearing potential must agree practice two effective form birth control ( outline participant information consent form ) throughout course study , start start Study Day 1 30 day stop study drug , 6 month stop study drug receive ribavirin ( RBV ) Plan receive multiorgan transplant Plan receive dual kidney transplant ( include en bloc ) Prior solid organ transplant Participating another study involve intervention investigational product Plan receive blood type incompatible kidney History human immunodeficiency ( HIV ) , hepatitis C ( HCV ) , active hepatitis B ( HBV ) infection define active antiviral treatment HBV , detectable hepatitis B surface Ag detectable hepatitis B DNA Active unresolved bacterial , viral , fungal infection clinically significant History cirrhosis preexist liver disease nonalcoholic steatohepatitis History illicit drug use alcohol abuse within 12 month prior screen Psychiatric physical illness opinion investigator would make unsafe proceed transplantation interfere ability subject participate study .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Renal</keyword>
	<keyword>Transplants</keyword>
	<keyword>Hepatitis C</keyword>
	<keyword>HCV-negative</keyword>
	<keyword>Infected</keyword>
	<keyword>Donors</keyword>
</DOC>